MK-8262 T38908

Product Introduction
Bioactivity


英文名: MK-8262

描述: MK-8262, an orally active and potent cholesteryl ester transfer protein (CETP) inhibitor (IC 50 = 53 nM, log D = 5.3), is a bistrifluoromethyl analogue that shows promise in research related to high-density lipoprotein (HDL) and low-density lipoprotein (LDL) with potential implications for coronary heart disease (CHD).

体外活性: MK-8262 (Compound 87) reduces cell viability in a dose-dependent manner beginning at ～10 μM in all 8 cell lines regardless of human CYP expression or glutathione depletion (HEK293/CYP cell lines expressing human CYP1A2, CYP2E1, CYP2D6, CYP2C8, CYP2B6, CYP3A4, CYP2C19, or CYP2C9)[1]. MK-8262 has no effect on human CYP protein concentration or Nrf2 activation in any of the 8 cell lines[1].

体内活性: MK-8262 (Compound 87; 10 mg/kg; orally) results in a significant HDL cholesterol increase in a 2-week chronic treatment of CETP transgenic mice[1]. MK-8262 (1 mg/kg; iv) has a T 1/2 MRT of 6 hours, a CL of 2.6 mL/min?kg, and a V ss of 0.95 L/kg for mouse[1]. MK-8262 (2 mg/kg; po) has a C max of 0.43 μM and an AUC of 7.9 μM?h for mouse[1]. MK-8262 (1 mg/kg; iv) has a T 1/2 MRT of 13 hours, a CL of 3.1 mL/min?kg, and a V ss of 2.4 L/kg for mouse[1]. MK-8262 (2 mg/kg; po) has a C max of 0.4 μM and an AUC of 9.7 μM?h for mouse[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: MK8262 | MK-8262 | MK 8262

MK-8262 T38908信息由TargetMol中国为您提供，如您想了解更多关于MK-8262 T38908报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途